UK warns of deadly risks in fake erectile dysfunction drugs flooding the market
UK warns of deadly risks in fake erectile dysfunction drugs flooding the market
UK warns of deadly risks in fake erectile dysfunction drugs flooding the market
The UK's medicines regulator has issued a fresh warning about the dangers of buying erectile dysfunction drugs from unregulated sources. Between 2021 and 2025, authorities seized over 19.5 million illegal doses—enough to fill two double-decker buses. Many of these counterfeit pills contained no active ingredient, the wrong dose, or even toxic substances hidden inside.
Erectile dysfunction affects around 4.3 million men in the UK, with half of those aged 40 to 70 experiencing the condition. Despite its prevalence, research shows that two in five men would avoid seeking medical advice, potentially turning to risky online sellers instead.
The Medicines and Healthcare products Regulatory Agency (MHRA) has highlighted the serious health risks of purchasing these drugs from unregulated websites, social media, or messaging apps. Many seized pills were found to contain incorrect doses, harmful additives, or no active ingredient at all. Some even included hidden drugs that could interact dangerously with other medications.
Sildenafil, commonly sold under the brand name Viagra, is particularly risky for men with certain health conditions or those taking specific medicines. The problem has grown rapidly, with seizures of illegal erectile dysfunction drugs more than doubling since 2022. In 2025 alone, over 4 million doses were confiscated by UK authorities.
UK regulators, including the MHRA and police, have carried out multiple operations to tackle the illegal trade. However, no public data exists on the exact number of criminal networks dismantled in recent years.
The MHRA continues to urge men to seek medical advice before using erectile dysfunction treatments. Buying from unregulated sources poses serious health risks, including exposure to fake or contaminated drugs. Authorities have seized enough counterfeit pills to supply three quarters of UK men with a single dose, underscoring the scale of the problem.